EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer

Vahid Khalaj iD, Alyssa M Waller iD, MacKenzie V Demmel iD, Urvinder Kaur Sardarni, Jack T Adams, Aidan Collier iD, Ana Maria Zaske iD, Majid Momeny, Jennifer M Bailey-Lundberg iD, Ali Azhdarinia iD

Pharmaceutics · 27.07.2026 · 18 (8) · 920

DOI: 10.3390/pharmaceutics18080920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.07.2026. Verfasst von Vahid Khalaj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH Shared Instrumentation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with a desmoplastic, immunosuppressive tumor microenvironment enriched in extracellular adenosine. High adenosine levels disrupt anti-tumor immunity by engaging adenosine receptors on T cells, macrophages, and dendritic cells. In this context, strategies to reduce extracellular adenosine signaling within the TME are in focus. Among them, enzymatic degradation of extracellular adenosine levels has emerged as a promising approach to overcome immune suppression and restore anti-tumor immune responses.

Methods

Here, we engineered an E. coli strain to express a surface-bound form of a bacterial ADA2 enzyme and used the outer membrane vesicles produced by this strain as nanoparticles carrying the functional enzyme. Our data indicate robust surface expression and enzymatic activity of ADA2 on OMV particles.

Results

In a PDAC subcutaneous flank tumor model, intratumoral administration of OMV-ADA2 particles was associated with significantly increased infiltration of CD8+ T cells and Granzyme B expression and concomitant decreases in collagen deposition and α-smooth muscle actin (α-SMA) positive stromal cells, suggesting modulation of the desmoplastic stroma.

Conclusions

These findings support further investigation of OMV–bADA2 as a potential platform to modulate tumor metabolism and stroma, activate anti-tumor immunity, and serve as a carrier for co-delivery of additional anticancer modalities in PDAC.

Schlagwörter

Stichwörter der Autor:innen

PDACadenosineadenosine deaminase 2bacterial surface displayimmunosuppressionouter membrane vesicletumor microenvironment

Autor:innen und Institutionen

  • Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Pathology, Microbiology and Immunology, The University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Fred & Pamela Buffett Cancer Center, The University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Department of Pediatric Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

ORCID-Profile: Vahid Khalaj, Alyssa M Waller, MacKenzie V Demmel, Aidan Collier, Ana Maria Zaske, Jennifer M Bailey-Lundberg, Ali Azhdarinia

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIH Shared Instrumentation
  • United States Department of Defense
  • John S. Dunn Foundation
  • National Cancer Institute of the National Institutes of Health
  • Department of Defense

Zitieren

APA

Khalaj, V., Waller, A. M., Demmel, M. V., Sardarni, U. K., Adams, J. T., Collier, A., Zaske, A. M., Momeny, M., Bailey-Lundberg, J. M., & Azhdarinia, A. (2026). ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. Pharmaceutics, 18(8), 920. https://doi.org/10.3390/pharmaceutics18080920

Vancouver

Khalaj V, Waller AM, Demmel MV, Sardarni UK, Adams JT, Collier A, et al. ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. Pharmaceutics. 2026;18(8):920. doi:10.3390/pharmaceutics18080920

BibTeX
@article{Khalaj2026,
  author = {Khalaj, Vahid and Waller, Alyssa M and Demmel, MacKenzie V and Sardarni, Urvinder Kaur and Adams, Jack T and Collier, Aidan and Zaske, Ana Maria and Momeny, Majid and Bailey-Lundberg, Jennifer M and Azhdarinia, Ali},
  title = {ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {920},
  doi = {10.3390/pharmaceutics18080920}
}
Kostenlos starten →